EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification
Open Access
Abstract
Background: Hepatocellular carcinoma (HCC) is a common malignant tumor. There are few studies on EXOSC10 (exosome component 10) in HCC; however, the importance of EXOSC10 for HCC remains unclear. Methods: In the study, the prognosis value of EXOSC10 and the immune correlation were explored by bioinformatics. The expression of EXOSC10 was verified by tissue samples from clinical patients and in vitro experiment (liver cancer cell lines HepG2, MHCC97H and Huh-7; normal human liver cell line LO2). Immunohistochemistry (IHC) was used to detect EXOSC10 protein expression in clinical tissue from HCC. Huh-7 cells with siEXOSC10 were constructed using lipofectamine 3000. Cell counting kit 8 (CCK-8) and colony formation were used to test cell proliferation. The wound healing and transwell were used to analyze the cell migration capacity. Mitochondrial membrane potential, Hoechst 33342 dye, and flow cytometer were used to detect the change in cell apoptosis, respectively. Differential expression genes (DEGs) analysis and gene set enrichment analysis (GSEA) were used to investigate the potential mechanism of EXOSC10 and were verified by western blotting. Results: EXOSC10 was highly expressed in tissues from patients with HCC and was an independent prognostic factor for overall survival (OS) in HCC. Increased expression of EXOSC10 was significantly related to histological grade, T stage, and pathological stage. Multivariate analysis indicated that the high expression level of EXOSC10 was correlated with poor overall survival (OS) in HCC. GO and GSEA analysis showed enrichment of the cell cycle and p53-related signaling pathway. Immune analysis showed that EXOSC10 expression was a significant positive correlation with immune infiltration in HCC. In vitro experiments, cell proliferation and migration were inhibited by the elimination of EXOSC10. Furthermore, the elimination of EXOSC10 induced cell apoptosis, suppressed PARP, N-cadherin and Bcl-2 protein expression levels, while increasing Bax, p21, p53, p-p53, and E-cadherin protein expression levels. Conclusions: EXOSC10 had a predictive value for the prognosis of HCC and may regulate the progression of HCC through the p53-related signaling pathway.Keywords
Funding Information
- Youjiang Medical College for Nationalities (YY2021SK02)
- Foundation of Nanning Qingxiu District Key Research and Development Project (2020023)
- Open Project of Guangxi key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer (GXEKL202203)
- Open Project Program of Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province (MIRRLAB 21SZDSYS13)
- Grant of Special Key Laboratory of Gene Detection & Therapy of Guizhou Province (Zunyi Medical University (QJKH-KY [2017]007-002)
- National-level Project of University Students’ Innovation and Entrepreneurship in 2022 (202210599005, 202210599007)
- Guangxi Provincial-Level Project of University Students’ Innovation and Entrepreneurship in 2022 (S202210599056)
This publication has 45 references indexed in Scilit:
- A pathology atlas of the human cancer transcriptomeScience, 2017
- Identification and validation of a prognostic 9-genes expression signature for gastric cancerOncotarget, 2017
- Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysisExpert Review of Gastroenterology & Hepatology, 2017
- Structure of a Cytoplasmic 11-Subunit RNA Exosome ComplexMolecular Cell, 2016
- The multiple functions of RNA helicases as drivers and regulators of gene expressionNature Reviews Molecular Cell Biology, 2016
- Robust enumeration of cell subsets from tissue expression profilesNature Methods, 2015
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- Activities of human RRP6 and structure of the human RRP6 catalytic domainRNA, 2011
- Seizure 6-Like (SEZ6L) Gene and Risk for Lung CancerCancer Research, 2007